Formulation and characterization of poloxamine-based hydrogels as tissue sealants

被引:49
作者
Cho, Eunhee [1 ]
Lee, Jeoung Soo [1 ]
Webb, Ken [1 ]
机构
[1] Clemson Univ, Microenvironm Engn Lab, Dept Bioengn, Clemson, SC 29634 USA
关键词
Hydrogel; Poloxamine; Michael-type addition; Thermosensitive; Sealant; FULLY-SYNTHETIC SUBSTITUTE; PPO-PEO TRIBLOCKS; BIOMEDICAL APPLICATIONS; BLOCK-COPOLYMERS; THERMAL GELATION; CROSS-LINKING; FIBRIN SEALANT; DRUG-DELIVERY; GENE-TRANSFER; IN-VITRO;
D O I
10.1016/j.actbio.2012.03.003
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In situ cross linkable polyethylene glycol (PEG)-based polymers play an increasing role in surgical practice as sealants that provide a barrier to fluid/gas leakage and adhesion formation. This study investigated the gelation behavior and physical properties of hydrogels formed from homogeneous and blended solutions of two acrylated poloxamines (Tetronics (R) T1107 and T904) of various molecular weights and hydrophilic/lipophilic balances relative to a PEG control. Hydrogels were formed by reverse thermal gelation at physiological temperature (T1107-containing formulations) and covalent crosslinking by Michael-type addition with dithiothreitol. All poloxamine-based hydrogels exhibited thermosensitive behavior and achieved significantly reduced swelling, increased tensile properties and increased tissue bond strength relative to the PEG hydrogel at physiological temperature. Swelling and tensile properties of all poloxamine-based hydrogels were significantly greater at 37 degrees C relative to 4 degrees C, suggesting that their improved physical properties derive from cooperative crosslinking by both noncovalent and covalent mechanisms. Poloxamine-based hydrogels were cytocompatible and underwent hydrolytic degradation over 2-5 weeks, depending on their T1107/T904 composition. In conclusion, select poloxamine-based hydrogels possess a number of properties potentially beneficial to tissue sealant applications. including a substantial increase in viscosity between room/physiological temperatures, resistance to cell adhesion and maintenance of a stable volume during equilibration. (C) 2012 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:2223 / 2232
页数:10
相关论文
共 63 条
[1]   Tetronic micellization, gelation and drug solubilization: Influence of pH and ionic strength [J].
Alvarez-Lorenzo, Carmen ;
Gonzalez-Lopez, Jaime ;
Fernandez-Tarrio, Marta ;
Sandez-Macho, Isabel ;
Concheiro, Angel .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 66 (02) :244-252
[2]  
[Anonymous], 2009, INSTR US
[3]  
[Anonymous], INSTR US
[4]   Hydrogel-induced cervicomedullary compression after posterior fossa decompression for Chiari malformation - Case report [J].
Blackburn, Spiros L. ;
Smyth, Matthew D. .
JOURNAL OF NEUROSURGERY, 2007, 106 (04) :302-304
[5]   Use of a novel absorbable hydrogel for augmentation of dural repair: Results of a preliminary clinical study [J].
Boogaarts, JD ;
Grotenhuis, JA ;
Bartels, RHMA ;
Beems, T .
NEUROSURGERY, 2005, 57 (01) :146-151
[6]   Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery [J].
Bromberg, LE ;
Ron, ES .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (03) :197-221
[7]   Thermal gelation and tissue adhesion of biomimetic hydrogels [J].
Burke, Sean A. ;
Ritter-Jones, Marsha ;
Lee, Bruce P. ;
Messersmith, Phillip B. .
BIOMEDICAL MATERIALS, 2007, 2 (04) :203-210
[8]   Towards a fully synthetic substitute of alginate: Optimization of, a thermal gelation/chemical cross-linking scheme ("Tandem" gelation) for the production of beads and liquid-core capsules [J].
Cellesi, F ;
Weber, W ;
Fussenegger, M ;
Hubbell, JA ;
Tirelli, N .
BIOTECHNOLOGY AND BIOENGINEERING, 2004, 88 (06) :740-749
[9]   Towards a fully-synthetic substitute of alginate: development of a new process using thermal gelation and chemical cross-linking [J].
Cellesi, F ;
Tirelli, N ;
Hubbell, JA .
BIOMATERIALS, 2004, 25 (21) :5115-5124
[10]  
Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO